Therefore, when IGF-1R expression is decreased, other receptor tyrosine kinases will compensate for the loss of downstream signaling following IGF-1R inhibition, causing the overexpression of HER2 in ovarian cancer cells and promoting both cell proliferation and differentiation to benefit the development of cancer as far as possible [69]. Here, IGF1R is linked to ovarian carcinoma.